Intracellular detection of laminin α2 chain in skin by electron microscopy immunocytochemistry: Comparison between normal and laminin α2 chain deficient subjects

Neuromuscular Disorders

Volumn 7, Issue 2, 1997, Pages 91-98

  Squarzoni, S ^a   Villanova, M ^b   Sabatelli, P ^a   Malandrini, A ^b   Toti, P ^b   Pini, A ^c   Merlini, L ^d   Guazzi, G C ^b   Maraldi, N M ^a,d  

^a CNR   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c Serv Neurol Pediat e Psichiatria   (Italy)

^d RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Cytoskeleton; Electron microscopy immunocytochemistry; Extracellular matrix; Laminin 2; Signalling; Thin section fracture label

Indexed keywords

LAMININ;

ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOGOLD STAINING; IMMUNOPEROXIDASE STAINING; KERATINOCYTE; MALE; MICROSCOPY; MUSCULAR DYSTROPHY; PRIORITY JOURNAL; SKIN; SKIN BIOPSY;

HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; MALE; MICROSCOPY, ELECTRON; SKIN;

EID: 0030938454     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(96)00420-8     Document Type: Article

References (27)

1. Leivo I, Engvall E, Merosin, a protein specific for basement membranes of Schwann cells, striated muscle and trophoblast is expressed late in nerve and muscle development. Proc Natl Acad Sci USA 1988;85:1544-48.
2. Vuolteenaho R, Nissinen M, Sainio K et al. Human laminin M chain (merosin): complete primary structure, chromosomal assignment and expression of the M and A chain in human fetal tissues. J Cell Biol 1994;124(3):381-94.
3. Villanova M, Malandrini A, Toti P et al. Localization of merosin in the normal human brain: implications lor congenital muscular dystrophy with merosin deficiency. J Submicrosc Cytol Pathol 1996;28(1):1-3.
4. Campbell KP. Three muscular dystrophies: loss of eytoskeleton extracellular matrix linkage. Cell 1995;80:675-79.
5. Tomé FMS, Evangelista T, Leclerc A. et al. Congenital muscular dystrophy with merosin deficiency. CR Acad Sci Paris, Sciences de la vie Life sciences 1994:317:351-57 Genetique Genetics.
6. Xu H, Christmas P, Wu XR, Wewer UM, Engvall E. Detective muscle basement membrane and lack of M-laminin in the dystrophic dy dy mouse. Proc Natl Acad Sci USA 1994;91:5572-76 Medical Sciences.
7. Sunada Y, Bernier SM, Kozak C, Yaniada Y, Campbell KP. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M gene chain to dy locus. J Biol Chem 1994;269(19):13729-32.
8. Shorer Z, Philpot J, Muntoni F, Sewry CA, Dubowitz V. Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status. J Child Neurol 1995;26:1-5.
9. Philpot J, Sewry CA, Pennock J, Dubowitz V, Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromusc Disord 1995;5:301-05.
10. Trevisan CP, Martinello F, Ferruzza E, Angelini C. Divergence of central nervous system involvement in 2 Italian sisters with congenital muscular dystrophy, a clinical and neuroradiological follow-up. Eur Neurol 1995;35:230-35.
11. Mercuri E, Muntoni F, Berardinelli A, Pennock J, Sewry CA, Philpot J, Dubowitz V. Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status. Neuropaediatrics 1995;26:3-7.
12. 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995;11:216-18.
13. Bernier SM, Utani A, Sugiyama S, Doi T, Polistina C, Yamada Y. Cloning and expression of laminin alpha 2 chain (M-chain) in the mouse. Matrix Biol 1995;14(6):447-55.
14. Monical PL, Kefalides NA. Coculture modulates laminin synthesis and mRNA levels in epidermal keratinocytes and dermal fibroblasts. Exp Cell Res 1994;210:154-59.
15. Sewry CA, Philpot J, Sorokin LM et al. Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy. Lancet 1996;347:582-84.
16. Pinto da Silva P. Freeze-fracture cytochemistry. In: Polak J.M., Varndell I.M., editors. Immunolabeling for electron microscopy. Amsterdam, Elsevier, 1984:179 88.
17. Cullen MJ, Walsh J, Roberds SL, Campbell KP. Ultrastructural localization of adhalin, alpha-dystroglycan and merosin in normal and dystrophic muscle. Neuropathol Appl Neurobiol 1996;22(1):30-37.
18. 2 chain in normal human skeletal muscle and peripheral nerve: an ultrastructural immunolabeling study. Acta Neuropathol. 1997;93:166.
19. Squarzoni S, Sabatelli P, Maltarello MC, Cataldi A, Di Primio R, Maraldi NM. Localization of dystrophin COOH terminal domain by the fracture-label technique. J Cell Biol 1992;118(6):1401-09.
20. Olsen D, Nagayoshi T, Fazio M et al. Human laminin: cloning and sequence analysis of cDNAs encoding A, B1 and B2 chains, and expression of the corresponding genes in human skin and cultured cells. Lab Invest 1989;60(6):772-82.
21. Chang AC, Wadsworth S, Coligan JE. Expression of merosin in the thymus and its interaction with thymocytes. J Immunol 1993;151:1789-1801.
22. 1 integrins mediate laminin merosinbinding and function as costimulatory molecules for human thymocyte proliferation. J Immunol 1995;154:500-10.
23. 5) and their relationship with the cytoskeleton and basement membrane matrix in cultured human keratinocytes. J Cell Biol 1991;112:761-73.
24. Juliano RL, Askill S. Signal transduction from the extracellular matrix. J Cell Biol 1993;120(3):577-85.
25. Roskelley CD, Srebrow A, Bissell MJ. A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Curr Opin Cell Biol 1995;7:736-47.
26. Forgacs G. On the possible role of cytoskeletal filamentous network in intracellular signaling: an approach based on percolation. J Cell Sci 1995;108:2131-43.
27. Hardiman O. Dystrophin deficiency, altered cell signalling and fibre hypertrophy. Neuromusc Disord 1994;4(4):305-15.